Economic Evaluation of Fractional Flow Reserve–Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease

医学 部分流量储备 经皮冠状动脉介入治疗 生活质量(医疗保健) 置信区间 冠状动脉疾病 质量调整寿命年 成本效益 经皮 心脏病学 内科学 急诊医学 冠状动脉造影 心肌梗塞 风险分析(工程) 护理部
作者
William F. Fearon,Bernhard Bornschein,Pim A.L. Tonino,Raffaella Matteucci Gothe,Bernard De Bruyne,Nico H.J. Pijls,Uwe Siebert
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:122 (24): 2545-2550 被引量:358
标识
DOI:10.1161/circulationaha.109.925396
摘要

The Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) study demonstrated significantly improved health outcomes at 1 year in patients randomized to multivessel percutaneous coronary intervention guided by fractional flow reserve (FFR) compared with percutaneous coronary intervention guided by angiography alone. The economic impact of routine measurement of FFR in this setting is not known.In this study, 1005 patients were randomly assigned to FFR-guided or angiography-guided percutaneous coronary intervention and followed up for 1 year. A prospective cost-utility analysis comparing costs and quality-adjusted life-years was performed with a time horizon of 1 year. Quality-adjusted life-years were calculated with the use of utilities determined by the EuroQuol 5 dimension health survey with US weights. Direct medical costs included those of the index procedure and hospitalization and costs for major adverse cardiac events during follow-up. Confidence intervals for both quality-adjusted life-years and costs were estimated by the bootstrap percentile method. Major adverse cardiac events at 1 year occurred in 13.2% of those in the FFR-guided arm and 18.3% of those in the angiography-guided arm (P=0.02). Quality-adjusted life-years were slightly greater in the FFR-guided arm (0.853 versus 0.838; P=0.2). Mean overall costs at 1 year were significantly less in the FFR-guided arm ($14 315 versus $16 700; P<0.001). Bootstrap simulation indicated that the FFR-guided strategy was cost-saving in 90.74% and cost-effective at a threshold of US $50 000 per quality-adjusted life-years in 99.96%. Sensitivity analyses demonstrated robust results.Economic evaluation of the FAME study reveals that FFR-guided percutaneous coronary intervention in patients with multivessel coronary disease is one of those rare situations in which a new technology not only improves outcomes but also saves resources. Clinical Trial Registration- URL: http://ClinicalTrials.gov. Unique identifier: NCT00267774.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
雪儿完成签到 ,获得积分10
1秒前
东方诩完成签到,获得积分10
3秒前
满意机器猫完成签到 ,获得积分10
3秒前
鲁卓林完成签到,获得积分10
3秒前
6秒前
在水一方完成签到,获得积分0
6秒前
jerry完成签到 ,获得积分10
7秒前
搞怪元彤完成签到,获得积分10
7秒前
英姑应助l123采纳,获得10
8秒前
苏苏完成签到 ,获得积分10
9秒前
搞怪元彤发布了新的文献求助10
10秒前
xavier完成签到,获得积分10
11秒前
凉笙墨染发布了新的文献求助10
11秒前
L3完成签到,获得积分10
13秒前
奥丁不言语完成签到 ,获得积分10
14秒前
慕冰蝶完成签到,获得积分10
15秒前
凉笙墨染发布了新的文献求助10
20秒前
李宗洋完成签到,获得积分10
22秒前
粗暴的醉卉完成签到,获得积分10
22秒前
Moeim Keller完成签到,获得积分10
24秒前
24秒前
l123发布了新的文献求助10
27秒前
xiaoxie完成签到 ,获得积分10
29秒前
俏皮诺言完成签到,获得积分10
32秒前
飞快的兔子完成签到,获得积分20
32秒前
研都不研了完成签到 ,获得积分10
34秒前
34秒前
凉笙墨染完成签到,获得积分10
35秒前
38秒前
方圆学术完成签到,获得积分10
42秒前
高山流水完成签到,获得积分10
42秒前
YSY完成签到 ,获得积分10
45秒前
行走的猫完成签到 ,获得积分10
46秒前
科目三应助搞怪元彤采纳,获得10
46秒前
xxxxffff完成签到,获得积分20
46秒前
Scheduling完成签到 ,获得积分10
47秒前
潜行者完成签到 ,获得积分10
47秒前
杨怡诗完成签到,获得积分10
47秒前
aldehyde应助monthli采纳,获得10
49秒前
50秒前
高分求助中
Pipeline and riser loss of containment 2001 - 2020 (PARLOC 2020) 1000
哈工大泛函分析教案课件、“72小时速成泛函分析:从入门到入土.PDF”等 660
Learning and Motivation in the Classroom 500
Theory of Dislocations (3rd ed.) 500
Comparing natural with chemical additive production 500
The Leucovorin Guide for Parents: Understanding Autism’s Folate 500
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5223264
求助须知:如何正确求助?哪些是违规求助? 4395751
关于积分的说明 13681872
捐赠科研通 4259790
什么是DOI,文献DOI怎么找? 2337504
邀请新用户注册赠送积分活动 1334912
关于科研通互助平台的介绍 1290414